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ABSTRACT
Sulphur mustard (SM) is a chemical warfare agent of historical and current interest It is a well
known blistering agent or vesicant SM was extensively used in world war I as a chemical weapon
and has been stockpiled by several counbies since that time. SM serves as an ideal war gas and is
favoured militarily for its ability to incapacitate rather than to kill. Its use resulted in large nUmbers of
casualties requiring prolonged and intensive medical care. Despite Geneva Protocol of 1925, which
categorically OOnned the production, stockpiling and use of chemical weapons in wars, SM has been
used in several wars, including the 1ran-1rnq war during the 1980s, which renewed interest in it.
Though, the chemical we'dpons convention was signed by more than 160 counbies in 1993 and was
subsequently ratified by several counbies, the threat from this agent persists due to its clandestine
usage during war and also by teITOrist groups. There is no effective and specific antido~ for local and
systemic toxicity of SM despite scientific research for more than 75 years. Many compounds were
tested as antidotes for SM, but very few of them have been shown to provide some protection. The
present review is aimed at evaluating the treatment regime and other clinical measures used to ~ SM
victims and the various drugs and chemicals screened as antidotes for SM poisoning in experimental
animals.
chemical warfare (CW) agents. For the first time,
basic biochemical research on CW agents and SM
was initiated independently by Dixon3 .and Peters4
at Cambridge University and Oxford University,
respectively. Later, the first clinical description of
the blisters and the lesions caused. by SM was
documented by Peters as 'biochemical lesion' s.
SM is a frequently used CW agent 6,7. Despite
the signing of chemical weapons convention in
1993 and its subsequent ratification by several
countries. the possibility of SM being used
clandestinely during a war or by terrorists still
exists due to t!te simple method of its preparation.
Hence. research is being carried out on the
identification of better decontamination agents and
I. INTRODUCTION
Sulphur mustard (SM) or mustard gas[I,1 '-thio
bis (2-chloroethane)] is a powerful blistering agent
that produces extensive injuries at the site of
exposure. It is one of the oldest known alkylating
agents and due to its potent incapacitating action, it
is called as 'king ofwaigases'. The first military
use of SM as a chemical weapon was made during
world war I ( 1917) by Germans against British
troops at Ypres in Belgium. This resulted in many
casualties due to lack of protective clothing and
ineffective medical treatmentl,2. The
physico-chemical properties of SM are given in
Table 1.
After world war I, Britishers showed concern
about carrying out their own strategic research on
Roceived 10 Apri11997 , revised 13 August 1997
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Table I. Physico-chemical properties or sulphur mustard
Properties of SM Values/d~tails
[505-60-2]
C4H8C/2S
158.08
5.8
1.27
217 °c
14.46 °c
0.069 at 20 °c
149 -177 °c
Several hypotheses have been proposed about
SM-induced toxicity. According to Papinneister,9
SM-induced DNA breakage leads to activation of
chromos-omal enzyme poly (ADP-ribose)
polymerase, which in turn, depletes cellular NAD+,
inhibits glycolysis,. and ultimately causes cell
death11. Another mechanism proposed for SM-
induced cytotoxicity is based on lipid peroxidation
occurring due to the fonnation of reactive oxygen
intennediates as a consequence of glutathione
(GSH) depletion 9,12. Still another mechanism is
based on the hypothesis that depletion of GSH can
increase intracellular Ca2+ causing cell death9
Since SM is a highly reactive molecule, it can
interact with a wide variety ofbiomolecules leading
to a condition similar to apoptosis or necrosis.
Increased excretion of uric acid in urine, usually
observed in such conditions, is also observed
following SM administration in experimental
animals, either topically or through inhalation.
8.5 min
Thiodiglycol and chloride
CAS registry No.
Chemical formula
Molecular weight
Vapour density
Liquid density at 25 °c
Boiling point
Freezing point
Vapour pressure (mm)
Decomposition temperature
Hydrolysis at 25 °c
(a) Rate
(b) Major products
Solubility in
(a) Water at 25 °c
(b) Organic solvents
0.8 gll
Readily soluble
antidotes for SM. Hundreds of chemicals and drugs
have been evaluated for their antidotal efficacy
against SM. But their efficacy is not satisfactory .
The present review is aimed at giving a description
of the decontamination agents and antidotes for SM
evaluated to date. To understand the use of various
antidotes, a brief description of the mechanism and
effects of SM is also given.
3. TARGET ORGANS
Eyes, skin and respiratory tract are the
principal target organs of SM toxicity. SM in
liquid, vapour or aerosol form attacks all the target
organs and causes injuries.
2. MECHANISM OF SULPHUR MUSTARD
TOXICITY
3.1.
Eye is the most vulnerable organ. Its exposure
to SM at 0:001 g m~ concentration for I hr can
cause irritation, itching, lacrimation, burning
sensation, conjunctivitis and photophobial3
Moderate and severe effects are marked hyperemia,
perforation in the anterior chamber and corneal
lesions. Studies on rabbit eyes indicate that
SM-induced injury to the cornea is characterised by
degeneration of epithelial cells, and the lesions are
similar to those in human victims. Keratopathy was
also observed in soI!1e war veteransl3. Large
scale exposure to SM results in a number of severe
eye lesions like corneal opacities, corneal
ulceration, delayed recurrent keratitis, chronic
conjunctivitis and keratoplasty9.
SM is a bifunctional and highly reactive agent.
It is documented as a genotoxic, mutagenic and
carcinogenic agent. At high dose levels, it exerts
cytotoxic effects8,9. Chemistry and biological fate
of SM have been investigated and reviewed
extensively9.10. SM owes its toxicity to spontaneous
form-ation of highly reactive and unstable
sulphonium compounds. These compounds undergo
intramolecular cyclisation and can react with a wide
variety of molecul~s of biological interest,
including proteins and nucleic acids. DNA is one of
the major targets of SM, producing inter-strand and
intra-strand adducts, leading to DNA strand
breakage.
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respiratory failure and death. Mice exposed to SM
vapours showed sensory irritation during exposure
and airway obstruction later16. Cancer of
respiratory tract, nasopharynx, larynx and lungs
have been reported in SM-exposed victimslo
3.2 Skin
SM penetrates the skin without appearance of
any warning signal, such as itching or burning. SM
is a highly Iyphophylic compound and gets
absorbed very quickly. However, the symptoms
may appear after a latent period of 6-24 hr,
depending upon the severity of exposure. Certain
regions of the body are particularly su$ceptible to
skin damage, because of their higher temperature
and humidity. The vulnerable regions are pubic
area (particularly the scrotum), the under-arms, the
neck, the skin between the fingers and between the
toes, and the area around the eyes 9,14. After one
day, blister formation on the epidermis reaches its
peak and it may be painful. Serous fluid containing
leukocytes accumulates in the blisters. SM
generally causes severe injury in fur covered
animals, because of a thin epidermis and densely
packed hair follicles1s. The skin of these animals
does not vesicate. However, the lesions are similar
to those observed in humans. The necrotic
epidermal tissue sloughs off after one week, .and the
granulating process starts at the border.
Histologically, heavy exudations of serum and
erythrocytes are detected. The blisters result in
harmful ulcers, which heal very slowly and tend to
become infec~ed. If they do not heal (after a month),
deep marginal pigmentation often develops.
4. CLINICAL MANAGEMENT OF SM
VICTIMS
Infonnation on clinical treatment of persons
exposed to SM has been reported since world war I,
from cases of exposure during wars, laboratory or
industrial work, experimentation on animals, or
sometimes, deliberate voluntary exposures.
However, substantial addition to knowledge has
come after the lran-Iraq conflict, and now improved
clinical management of SM victims has become
possible as highly sensitive and selective laboratory
parameters are available1'.
4.1 Treatment for Eye Effects
Exposure of the eyes to SM, even at low dose
can be incapacitating. Although, eye is one of the
target organs, only limited studies on animals have
been reported. The path9logical findings are similar
to those for most chemical injuries. On exposure to
liquid SM or its vapours, the eyes should be washed
with uncontaminated water as quickly as possible.
Since SM gets absorbed rapidly, washing should be
done within 2 min.
Momeni18 treated SM victims from Iran by
irrigating with Ringer's solution and applying
1 per cent cyclopenolate or 15 per cent
sulphacetamide in hydroxy propylmethyl cellulose
or chlorotetracycline eye ointment. Borak and
Sidel19 suggested that patients with SM ocular
injuries should be treated in the same way as- for
other chemical injuries. Severe corneal ulceration
may require months to heal. The general treatments
for eye lesions are listed in Table 2.
3.3 Respiratory Tract
Inhaled SM injures the respiratory epithelium
from the nasopharynx to the bronchioles.
Incapacitating airway injury occurs through vapour
exposures that are significantly lower than those.
producing severe skin blisters. In case of recent
war-exposed humans, symptoms like cough, chest
pressure, sinus pain, sore throat and hoarseness
have been observed on immediate exposure 14
However, the symptoms progress into
bronchospasm, bronchiolar obstruction by sloughed
epithelium and secretions, haemorrhagic
pulmonary edema, and secondary pneumonia over a
period of time. Death after SM exposure generally
occurs due to bronchopneumonia and secondary
infections. Severe exposure can also lead to
4.2 Treatment for Skin Effects
SM may persist as a liquid on contaminated
skin, clothing, leather and equipment for many
hours or days depending on physical conditions.
Battlefield protection against SM exposure requires
wearing of gas mask, protective clothing and gloves
(physical protection). Special materials are used
1~7
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Table 3. Decontamination agents Cor SMTable 2 .1ieabnent for eye effects
Symptoms Treatment
Contamination of the eye Wash with uncontaminated
watel" within 2 min
Sterile petroleum jelly
Pilocarpine or neostigmine
Two drops of sodium
sulphacetamide should be
instilled (30 %) every 4-8 hr.
Chlorotetracycline eye ointment
chloramphenicol, gentamicin
and neomycin can also be used.
Sticky eyelids
Severe photophobia
Secondary infection
Agents References
Physical agents
Fuller's earth 20,21
Charcoal 22
Talcum powder 23
Tissue paper 23
Flour 23
Abrasives 23
Salad oil 23
Household detergents 23
Chemical agents
DS-2 24
FOPS 24
Povidone iodine 22
Trichloracetic acid 25
Thiodiglycolic acid 25
Bleaching powder or 2,9
Calcium hypochlorite
Potassium permanganate 2,9
0.5 % HTH 23
Chloramine- T 2
Dichloramine- T 2
CC-2 20,21
M-5 26
~---
patients with severe genital skin damage. Various
treatments recommended for SM skin lesions are
listed in Table 4.
4.3 Treatment for Respiratory Effects
For SM victims v.jith severe respiratory
problems, endotracheal intubation should be
considered. If airway obstruction precludes
intubation, cricothyroidectomy may be performed.
Inhalation of moist air and use of mucolytics, such
as N-acetyl cysteine, are prescribed for patients
with respiratory complaints. Supplemental oxygen
through an endotracheal tube with positive
end-expiratory pressure is indicated for severely
hypoxic patients. Aspiration of bronchoalveolar
lavage or charcoal hemoperfusion is useful at any
stage of respiratory injury caused by SM19. Other
commonly used treatment for SM-induced
respiratory injury are given in Table 5.
for making protective clothing, since cotton, rubber
and latex are no barriers for the entry of SM.
Generally, butyl rubber is used for providing
physical protection. To improve the ability for
physical protection, a number of materials with
very good adsorptive capacity, like activated
carbon, can be impregnated in the clothing.
SM penetrates the skin rapidly and should be
decontaminated immediately. A variety of physical
and chemical methods are available for this purpose
(Table 3). If the decontamination is not carried out
immediately, the skin will be affected by .liquid
SM. In the absence of a satisfactory antidote for
SM, decontamination is given the priority. Medical
personnel attending on SM victims should also wear
protective clothing and prior precautions should be
taken to decontaminate the skin.
MomeniIB studied the cases of 535 Iran war
victims and suggested the following treatment for
skin manifestations of SM: Daily bath with dilute
(1/10,000) KMnO4 solution, and local application
of calamine, .promethasine containing lotion,
caladryl lotion or sterile petroleum jelly. Skin
ointments like 1 per cent silver sulphadiazine, 0.2
per cent nitrofuracine and 1 per cent hydrocortisone
were also recommended.
Blisters were aspirated, big bullae were opened
and open wounds were kept on sterile sheets.
Patients who experienced severe pain during
dressing were given morphine sulphate. A variety
of antibiotics were used both locally and
systemically. Urinary catheter was used for those
4.4 General Precautions
In general, victims may suffer from
dehydration as a result of extensive SM -induced
skin bums and fluid accumulation in edematous
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Table 4. Treatment for skin effects of SM exposure
-
Table 6. Dru~ and chemicals tested against toxic effects of SM
Drugs or chemicalsSymptoms References
Anti-inflammatory agents
Dexameth~one 27
Betamethasone 23
Promethazine 27
Prednisolone 28
Hydrocortisone 9
Cortisone 9
Anti-oxidants and inhibitors of lipid peroxidation
Vitamin-A 12,29
Vitamin-C 12,29
Vitamin-E 12,27,29
Hydroxyethyl rutoside 12,29
Gossypin 12,29
Sulphur mustard scavengers
Sodium thiosulphate 12,21
N-acetyl-L-cysteine 31,3~
BAL 9,33
2-Aminoethylisothiourea (AET) 33
DisulfIram 33
Dimethylsulphoxide 33
Dithiocarbamates 34
Thiophosphonates 34
Sodium diethyl dithiophosphate 9
Sodium diethyl dithiocarbamate 9
2-Mercaptoethanol 33
Cysteine 34
Cystine 33
Radioprotectors (WR-2721, WR-3689, 9,33
WR-638, etc.)
Inhibitors or cell death and promoters or cell survival
35,36
11,35
9
11
11
Treatment
Contaminated skin Decontamination
Persistent itching and severe Compound calamine lotion
erythema or petroleum jelly
Disinfectants Chlorhexidine hydrochloride
(0.5 %) or povidone-iodine
containing soap
Severe itching in the genital Xylocaine or prilocaine, or
area corticosteroids like
flumethasone and
triamcinolone. Systemic
analgesics like paracetamol,
pethidine and morphine and
antihistamines like clemastin
or promethacene
Mustard blisters Sterile petroleum jelly and
povidone-iodine ointment
Antibacterial drug, locally or
systemically
Secondary infection
tissues. Although, fluid requirements are generally
less than thermal bums, intravenous solutions were
used for all patients daily by monitoring blood fluid
balance and se-rum electrolytes concentrationl7
Table S. 1ioeatment for respiratory tract effects of SM
Symptoms Treatment
Treatment not required
Codeine
Alkaline gargle
Eye and nose drops
Antibacterial drugs
37
Niacinamide
Nicqtinamide
NAD
3-Aminobenzamide
3-Methoxybenzamide
Nicotinic acid
Glutathione
Calcium gluconate
Miscellaneous agents
Mild injury
Cough
Pharyngitis
Nasal irritation
Severe respiratory tract
injury
Laryngitis and tracheitis
Restlessness
30
27
27, 37
38
33
28
28
17
39
39
28
9
9
Other drugs
Steam inhalation
Sedation by morphine or
barbiturates
Acetyl cysteine.
corticosteroid spray.
aminophylline. theophylline.
terbutaline.
dextromethorphan with
ammonium chloride
Tracheostomy to relieve
pharyngeal obstruction due
to pseudomembranes or
mechanical cleaning
Severe exposure
Sodium citrate
Heparin
Atropine sulphate
Sodium ethanemonothiophosphonate
2-Aminoethanol
Salbutamol
Carbamazepine
Dithiothreitol
5 % Dextrose
Dextrose saline
Opioids
Allopurinol
Oxypurinol
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Nutritive diet should be given to SM-exposed
victims. Gastrointestinal problems were not
generally found in SM-exposed victims. Mild
problems like nausea, headache, etc., may be
treated symptomatically and liberal use of systemic
wide spectrum antibiotics and analgesics is also
recommended. In massive exposure, SM may
induce severe leukopenia and in this case whole
blood transfusion or plasma expanders should be
considered.
6. Somani, S.M. & Babu,
sulphur mustard. Int. I.
Toxicol., 1989, 27,419-
7. United Nauons Security Council. Report of the
mission despatched by the Secretary General to
investigate allegations of the use of chemical
weapons in the conflict between the Islamic
Republic of Iran and Iraq. UN. Security council,
New York,1988. Report No. S-20134.
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of action of cytotoxic alkylating agents. AnnlL
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9.
5. ANTIDOTES TO SULPHUR MUSTARD
POISONING
There is no specific' antidote against SM
intoxication and also no pretreatment is available to
avoid SM injuries. Several hypotheses have been
proposed for SM toxicity and various treatments
have been tried in experimental animals. But all the
drugs and chemicals screened so far have given
only limited protection and there is no satisfactory
antidote for ~M toxicity. Drugs and chemicals
screened for thCir antidotal efficacy, against SM are
listed in Table 6.
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